Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui, J Deanfield… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods In SOUL, the effects …
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui, J Deanfield… - Diabetes, Obesity and …, 2023 - cdr.lib.unc.edu
Aim: To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui… - Diabetes …, 2023 - researchinformation.amsterdamumc …
Aim: To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
[PDF][PDF] Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or …
DK McGuire, RP Busui, J Deanfield, SE Inzucchi… - 2023 - publications.rwth-aachen.de
Aim: To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
[PDF][PDF] Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or …
DK McGuire, RP Busui, J Deanfield, SE Inzucchi… - 2023 - core.ac.uk
Aim: To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui… - Diabetes …, 2023 - utsouthwestern.elsevierpure.com
Aim: To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui, J Deanfield, SE Inzucchi… - 2023 - pubmed.ncbi.nlm.nih.gov
Aim To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods In SOUL, the effects …
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui, J Deanfield… - Diabetes, Obesity & …, 2023 - europepmc.org
Aim To describe the design of Semaglutide cardiOvascular oUtcomes triaL (SOUL) and
baseline clinical data of its participants. In SOUL, the effects of oral semaglutide, the first oral …
baseline clinical data of its participants. In SOUL, the effects of oral semaglutide, the first oral …
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic …
DK McGuire, RP Busui, J Deanfield… - Diabetes, Obesity …, 2023 - discovery.ucl.ac.uk
Aim: To describe the design of the SOUL trial (Semaglutide cardiOvascular oUtcomes triaL)
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …
and the baseline clinical data of its participants. Materials and methods: In SOUL, the effects …